Crossmark

Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance)

Crossref DOI link: https://doi.org/10.1007/s00198-015-3091-4

Published Online: 2015-03-07

Published Print: 2015-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Dueck, A. C.

Singh, J.

Atherton, P.

Liu, H.

Novotny, P.

Hines, S.

Loprinzi, C. L.

Perez, E. A.

Tan, A.

Burger, K.

Zhao, X.

Diekmann, B.

Sloan, J. A.
License Information

Text and Data Mining valid from 2015-03-07